medical research
-
FDA Advisory Panel Unanimously Backs a Half-Dose Moderna Booster for Covid-19
On Thursday afternoon, experts assembled by the Food and Drug Administration recommended boosters for older and high-risk Americans who originally got the Moderna covid-19 vaccine. The unanimous vote will pave the way for an expected authorization of the booster by the FDA and Centres for Disease Control and Prevention. Unlike the recently sanctioned booster for…
-
Moderna Plans to Build $689 Million Vaccine Factory in Africa
Pharmaceutical firm Moderna plans to build a vaccine factory in Africa that will cost as much as $US500 ($689) million, according to a press release from the company early Thursday. Moderna will soon start the process of site selection on the continent and it’s already been narrowed down to about five unnamed countries, according to…
-
FDA Authorizes Pfizer Boosters for People 65 and Older and Those at High Risk for Severe Covid-19
After weeks of wondering who will get covid-19 booster shots and when — and receiving confusing advice from a variety of public officials — the Food and Drug Administration has made a decision.
-
UK to Recommend Covid-19 Booster Doses for Older and High-Risk People
New data from the UK suggests that some vaccinated people, particularly seniors, experience a greater loss in protection over time against covid-19 symptoms and severe illness than the general public. The findings were enough for the country’s vaccine experts to recommend booster shots for higher-risk groups, including all adults over 50.